Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Total Liabilities: 2015-2025

Historic Total Liabilities for Mesoblast (MESO) over the last 9 years, with Jun 2025 value amounting to $187.2 million.

  • Mesoblast's Total Liabilities fell 0.82% to $187.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $187.2 million, marking a year-over-year decrease of 0.82%. This contributed to the annual value of $187.2 million for FY2025, which is 0.82% down from last year.
  • Mesoblast's Total Liabilities amounted to $187.2 million in Q2 2025, which was down 2.51% from $192.1 million recorded in Q4 2024.
  • Mesoblast's 5-year Total Liabilities high stood at $192.1 million for Q4 2024, and its period low was $161.6 million during Q4 2023.
  • Moreover, its 3-year median value for Total Liabilities was $177.8 million (2023), whereas its average is $177.6 million.
  • As far as peak fluctuations go, Mesoblast's Total Liabilities decreased by 11.37% in 2021, and later climbed by 18.88% in 2024.
  • Quarterly analysis of 5 years shows Mesoblast's Total Liabilities stood at $168.9 million in 2021, then dropped by 0.52% to $168.1 million in 2022, then fell by 3.87% to $161.6 million in 2023, then grew by 18.88% to $192.1 million in 2024, then declined by 0.82% to $187.2 million in 2025.
  • Its Total Liabilities stands at $187.2 million for Q2 2025, versus $192.1 million for Q4 2024 and $188.8 million for Q2 2024.